JP2004173675A - Bacterium-encapsulated product having chemical-resistant property and method for producing the same - Google Patents
Bacterium-encapsulated product having chemical-resistant property and method for producing the same Download PDFInfo
- Publication number
- JP2004173675A JP2004173675A JP2003054955A JP2003054955A JP2004173675A JP 2004173675 A JP2004173675 A JP 2004173675A JP 2003054955 A JP2003054955 A JP 2003054955A JP 2003054955 A JP2003054955 A JP 2003054955A JP 2004173675 A JP2004173675 A JP 2004173675A
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- coagulant
- fungus
- solution
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【0001】
【発明に属する技術分野】
この発明は健康食品であるヨーグルト等の腸内有用菌を胃液、胆汁等の酸アルカリなどから保護して腸内に供給することで、整腸作用を強化した耐胃液性や耐胆汁性等の耐化学剤性を有する菌封入物に関するものである。
【0002】
【従来の技術】
従来、ヨーグルト等腸内有用菌は食べたとき、胃液、胆汁によって死滅し、腸内に生きたまま届く腸内有用菌は極めてわずかであると知られている。このため、腸内有用菌をカプセルまたはマイクロカプセルに封入した健康食品があった。腸内有用菌の餌となるオリゴ糖を一緒にカプセルに封入する考えもあった。また、ヨーグルトに少量のゼラチンやペクチンや寒天を添加したヨーグルト製品はあるが、これは滑らかな舌触りや製品の形状を保つために添加剤として使われている。また、菌の粉体を圧力で固めたものもある。(例えば特許文献1、2参照)
【0003】
【特許文献1】
特開平8−242763号公報
【特許文献2】
実願平10−1149号公報
【0004】
【発明が解決しようとする課題】
これには次のような欠点があった。
(イ)カプセルやマイクロカプセルに乾燥させた腸内有用菌を閉じ込める方法があるが、工程が複雑で高価であり、噛むと被膜が破れ、腸内有用菌を胃液から守る効果がなくなる。
(ロ)少量のゼラチンや寒天でヨーグルトの凝固を補助した食品は、食すると舌触りがよく美味である。しかし、ゲルの強度が弱く、水を加えるなり、振動を加えるなりしただけで、形が崩れ、またはゲルが溶け出してしまい、腸内有用菌を胃液や胆汁から守る効果は少ない。
(ハ)ヨーグルトを寒天などの凝固剤と混ぜて凝固させると、ヨーグルトと凝固剤が一部分離し、均質である製品を製造することは難しい。この方法は、ただ混ぜてあるのみで、菌の密度を増すことはできず、また、ゲルの網目構造の細部に菌をもぐりこませることは難しい。
(ニ)カプセル封入の方法は、腸内有用菌とオリゴ糖だけなので、腸内有用菌の繁殖場所になる食物繊維は含まれていない。
【0005】
【課題を解決するための手段】
図1の構造概念図のように、菌を凝固剤で固められた凝固化固形物などの固体に分散させ、胃液などの酸、胆汁などアルカリ、あるいは殺菌剤などの化学剤、または熱など外界らの刺激から菌を保護する構造になっている。本発明に用いる菌は、特に限定されるものではないが、乳酸菌、ビフィズス菌、フェーカリス菌、アシドフィルス菌、または、ヨーグルトに使われるケフィア菌、カスピ海ヨーグルト菌等などである。凝固化固形物がゲルである場合、ゲルで菌が囲まれており、胃液、胆汁に含まれる、酸、アルカリ等の濃度勾配に従う拡散速度が減速する。そのため、酸、アルカリ、または殺菌剤が浸透する浸透速度が遅くなり、耐化学剤性が高まる。耐化学剤性とは、耐胃液性すなわち耐酸性、耐胆汁性すなわち耐アルカリ性、耐殺菌剤などである。
【0006】摂取するときに、噛むことで砕かれても、凝固化固形物中に菌が分散しているため、凝固化固形物で菌は常に保護されている。一方、図2のように、菌をマイクロカプセル等の被膜で覆う方法であると、摂取時に噛むと被膜が破れ、耐化学剤性を有しなくなる。
【0007】製法手段として、培養液に寒天等の食べることができる凝固剤と菌を加え、凝固し発酵、または発酵と凝固を同時に行う。この凝固発酵により、凝固剤入り培養液に菌が分散した状態で発酵し、菌の数が増え、乳酸などの有効成分も生産され、ゲルの網目構造の隅々まで、菌が入り込み均質な製品が簡便に得られる。
【0008】凝固剤で固められた乳酸菌等の菌類を、乾燥または脱溶媒させ、水分等を少なくすると、常温保存ができ、胃液、胆汁が浸透していく浸透速度がさらに遅くなり、耐化学剤性がいっそう高まる。また、菌の密度も増やすことができる。凝固剤の量が少ない場合でも、乾燥させることで、固体の強度が強くなり、耐化学剤性が高くなる。
【0009】凝固剤は、寒天、ペクチン、ゼラチン、蒟蒻などのマンナン、ガラギナン、キサンタンガム、アルギン酸、ローカストビーンガム、デンプン、フノリ、アラビアゴム等のゲル化剤または接着剤を含む。また凝固剤の組み合わせは、腸内に腸内有用菌を生きたまま到達させるために、胃液や胆汁に対して耐化学剤性を有し、腸内では腸溶性を有することが望ましい。
【0010】以上のような構造または製造方法からなる耐化学剤性を有する菌封入物およびその製造方法である。
【0011】
【発明の実施の形態】
【実施例】以下、本発明の実施の形態を説明する。
【0012】実施例1 図3にもとづいて説明する。
第1工程 水に凝固剤兼食物繊維である寒天を混合し、沸騰して煮溶かし、凝固剤溶液を製造する。この実施例では水と寒天の重量比25:1で行い、4%の凝固剤溶液を作った。この工程では、凝固剤が溶け出す温度まで温度を上げる必要がある。凝固剤は、第9工程で凝固する程度以上の量が必要である。ゲルの固さを示すゼリー強度は、自然寒天である角寒天や糸寒天で250〜400g/cm2 である。凝固剤の性質にもよるが、寒天の場合、耐胃液性をもたせるため、この値付近またはそれ以上が望ましい。
第2工程 砂糖とてんさい糖を混ぜて、混合糖を製造する。この実施例では砂糖とてんさい糖の重量比5:1で行った。この工程で使われる糖分は、甘味の役割と菌の培養液の役割を兼ねている。
第3工程 第1工程の凝固剤溶液に第2工程の混合糖を混合し、糖凝固剤溶液を製造する。この実施例では20%の糖凝固剤溶液になった。
第4工程 培養液である牛乳を、糖凝固剤溶液を混ぜたとき、溶液が凝固しない程度の温度まで温める。この実施例では50℃で行った。
第5工程 第3工程で出来た糖凝固剤溶液に等重量の第4工程の培養液を加えて混ぜ、培養凝固剤溶液を製造する。
第6工程 培養液である牛乳に等重量のヨーグルトを入れ撹拌し、発酵に適した温度まで温め、種溶液を製造する。種を溶液にすることで、培養凝固剤溶液に分散しやすくなる。菌の繁殖には最適温度があり、温度を上げすぎると、死滅してしまう。また、種溶液の温度が低すぎると、培養凝固剤溶液に混ぜた場合、撹拌の段階で、凝固してしまい、培養凝固剤溶液中に菌を充分に分散することができなくなる。この実施例では35℃で行った。
第7工程 第5工程の培養凝固剤溶液を凝固しない程度まで冷やす。培養凝固剤溶液が熱すぎると、種溶液と混ぜたときに、菌が死滅してしまう。この実施例では50℃で行った。
第8工程 第7工程の培養凝固剤溶液と第6工程の種溶液を重量比3:1で混合し、撹拌することで、菌の種を分散し接種する。この時、好みに応じ、香料、エキスやフルーツを加えてもよい。この実施例では、培養凝固剤溶液50℃、種溶液35℃であり、撹拌した時点で、45℃付近である。凝固剤や菌の種類により、培養凝固剤溶液が固まらず、菌が死滅しにくい温度になるように、培養凝固剤溶液と種溶液の温度と重量比を決める必要がある。
第9工程 第8工程の混合液を適温にして凝固発酵させる。この実施例においては35℃で行った。菌の種類によって、適温である発酵温度が異なる。本実施例では、35℃位では既に混合物は凝固しており、凝固した状態で発酵が進む。発酵温度が高く、発酵時に凝固しない場合は、一旦、温度を下げ、凝固させてから、発酵温度を上げることが好ましい。ゾル−ゲル転移は、温度、圧力、化学物質、光線、電界等で、起こり、ヒステリシス現象を伴うことが多い。例えば、寒天の場合、濃度にもよるが、80℃付近でゾル化し、40℃付近でゲル化する。そのため、一旦温度を下げ、凝固させると、温度を上げても溶け出さず、固体の状態で発酵できる。
【0013】なお、第8工程で腸内有用菌が熱で死滅しないよう、直ちに第9工程に移ることが望ましい。しかし多少死滅しても、第9工程で発酵させ増やすことができる。第6工程で種溶液を製造しているが、粉末または固形状態の種を直接第8工程で、菌の種を入れてもよい。
【0014】耐化学剤性をさらに増したい場合、寒天等の凝固剤の割合を増やすとよい。逆に、凝固剤の割合を少なくすると、やわらかい口当たりになる。ダイエットには牛乳の代わりにスキムミルクを使用してもよい。腸内有用菌が繁殖しやすくするため、糖類、ビタミン、ミネラル等を培養液に混合してもよい。凝固発酵し終わったものを食するときは、(イ)そのまま食べるか、角切り等適度な大きさにしシロップ等をかけて食べる。(ロ)粒状等小片にしてドリンクに混ぜて飲む。または他の食品に混ぜて食べる。(ハ)乾燥させたものを、他の食品に混ぜて食べる。
【0015】以上のように、培養液に寒天等の食べることができる耐胃液性の凝固剤と腸内有用菌を加え、凝固し発酵、または発酵と凝固を同時に行うという方法により、凝固剤入り培養液に腸内有用菌等を均一に分散させることを特徴とする製造方法である。
【0016】実施例2:凝固剤の混合タイプ 実施例1の第1工程で複数の凝固剤を使用する。例えば、凝固剤として寒天、デンプンを使用し、水、寒天、デンプンの重量比25:1:0.5で混合し、沸騰して煮溶かし、凝固剤溶液を製造する。重量比はデンプンの種類や出来上がりの固さにより変えるとよい。第2工程以降は、実施例1と同様である。寒天、デンプン以外にもペクチン、ゼラチン、フノリ、アラビアゴムなどの凝固剤を複数組み合わせてもよい。このように、凝固剤を混合することで、耐化学剤性を調整でき、腸液で溶け出しやすい最適な凝固剤の組み合わせを特徴とする物を提供できる。
【0017】実施例3:食物繊維強化タイプ 実施例1の第1工程でマンナン、フスマなどの食物繊維を添加する。たとえば、水、寒天、マンナンを重量比251:0.1で混合し、沸騰して煮溶かし、凝固剤溶液を製造する。第2工程以降は、実施例1と同様である。すなわち、マンナン、フスマなどの食物繊維を強化することで、腸内有用菌が腸内で増殖しやすい環境を供給することを特徴とする物を提供できる。
【0018】実施例4:ミネラル・ビタミン・食物抽出エキス強化タイプ 実施例1から実施例3で凝固させる前の工程でカルシウム、マグネシウム、鉄等のミネラル類、各種ビタミン、または食物の抽出物あるいは食物を加える。食物はハーブやスパイスでもよく、発酵させたものでもよい。マグネシウムなどの場合下剤機能があり、ハーブには薬効等の機能がある。すなわち、ミネラル、ビタミン、または食物抽出エキスの少なくとも1つを強化することで、人、動物等の生体に栄養素、機能を同時に供給できることを特徴としたものを提供できる。
【0019】実施例5:菌の混合タイプ 腸内では様々な菌が共存している。そこで、実施例1から実施例4において、複数の菌を種として用いてもよい。すなわち、複数の菌を組み合わせることで、各個人の腸内で定着しやすい菌の組み合わせを作ることを特徴とする物を提供できる。
【0020】実施例6:嫌気菌タイプ 実施例1から実施例4において、嫌気菌を種とした場合、嫌気菌が発酵できるように、炭酸ガス、窒素ガス等封入状態で工程を処理するか、ビタミンC等の還元剤や酸素吸収剤を入れるか、発酵の工程で容器の内側にビニール等で中蓋をして、空気を閉め出すか、または密閉できる容器に流し込み、凝固発酵か、凝固したものを取り出し、密閉できる容器に移し発酵し、嫌気菌であるビフィズス菌等を増殖する。腸内は嫌気菌が主に繁殖する。すなわち、嫌気菌を増殖させることを特徴とした方法を提供する。
【0021】実施例7:嫌気菌と好気菌共存タイプ 実施例1から実施例4において、嫌気菌と好気菌を混合した種を用いる。凝固発酵する際、外から酸素が入り込まないよう、密封した容器で培養する。初め好気菌が増殖し酸素が消費された後、嫌気菌が増殖する。すなわち、好気菌と嫌気菌を共存増殖させることを特徴とした方法を提供する。
【0022】実施例8:直接分散凝固法 菌の粉末または疎水性を有する油などに菌の粉末を混ぜたものを直接、凝固剤に混ぜ分散させ、凝固させる方法。大豆油、オリーブ油、ゴマ油、胚芽油、ヤシ油、菜種油、グレープシード油等の疎水性の物質に菌を混ぜた物を、凝固剤溶液に分散させ凝固させると、耐化学剤性が高まる。実施例1や実施例2などの第1工程で、凝固剤溶液を作った後、凝固点に達しない温度まで下げる。寒天ならば、40℃位まで下げる。菌の粉末または疎水性を有する油などに菌の粉を混ぜたものを凝固剤溶液に加え撹拌し、分散させて凝固させる。または、実施例1の第8工程で種溶液の代わりに、菌の粉末を入れるか、または疎水性を有する油などに菌の粉を混ぜたものを入れる。これは、腸内に菌が増殖する栄養を同時に加える効果になる。
【0023】嫌気菌の場合、炭酸ガス封入で行うか、ビタミンC等の還元剤を加えるとよい。凝固溶液に、食物繊維、ミネラル、ビタミン、または食物の抽出エキスの少なくとも1つを混ぜてもよい。凝固剤の溶媒は、水以外の物質でもよい。菌の粉末を溶媒に混ぜ、凝固剤溶液に加えてもよい。すなわち、凝固剤溶液、または凝固剤溶液に培養液、食物繊維、ミネラル、ビタミン、食物抽出エキスの少なくとも1つを混ぜた物に菌粉末または疎水性物質に菌の粉末を混ぜたものを分散させ、固体にすることを特徴とする菌封入物の製造方法である。
【0024】実施例9:強度強化タイプ カルシウムイオン、マグネシウムイオン、カリウムイオン、高分子の荷電物質等のある種の化学物質で、凝固を促進し、または架橋構造などで固体の強度を強化し、水素イオン、水酸化物イオンなどの浸透速度を減速してもよい。実施例1から実施例8の凝固の工程で加えてもよい、または凝固の後で浸してもよい。このように本実施例により、実施例1から実施例8などにおいて、化学物質で凝固を促進、または固体の強度を強化した菌封入物を提供することができる。
【0025】実施例10:乾燥タイプ 乾燥することで、菌が眠った状態になり、常温保存ができる。菌の密度も高くなる。凝固剤で固められた固体の強度が強くなり、酸、アルカリ、殺菌剤等の化学剤が浸透していく浸透速度がいっそう遅くなり、耐酸性、耐アルカリ性等の耐化学剤性が高まる。凝固剤が少ない場合でも、濃縮されることで、耐化学剤等が高まる。実施例1から実施例9で凝固発酵または凝固して得られたものを適度な大きさにカットし、乾燥させる。または、実施例1から実施例9で凝固発酵または凝固して得られたものを乾燥してから適度の大きさにカットしてもよい。乾燥方法は、日陰干し、冷風乾燥、温風乾燥、常温減圧乾燥、低温減圧乾燥またはフリーズドライ等の処理でもよい。遠心力、圧搾等を利用して、溶媒を搾り出してもよいし、搾り出してから、上記の乾燥方法を用いてもよい。溶媒を搾り出すことで、早く乾燥できる。
【0026】実施例1で得られたものを、適度な大きさにスライスし、日陰干し、ゴム状の物体が得られた。厚さ1.5mm位で約15mm角のものを2倍に薄めた家庭用塩素系漂白剤(カネヨキッチンブリーチ)に1時間浸した。その後、水洗いし、1時間水に浸したものを、熱湯消毒したビンに牛乳とともに入れ、密閉し、48時間室温で放置したら、発酵した。同様に牛乳のみの場合の比較実験を行ったが発酵しなかった。
【0027】乾燥させた物を粒状にして摂取してもよい。サイズは、耐化学剤性が保てる程度の大きさから、飲み込める程度の大きさである。例えば、最少のサイズは、マイクロカプセルタイプの被膜の厚さ程度あれば、十分である。形は、立方体、球体、紡錘形、円盤形、三角形、六角形等の錠剤にしてもよい。飲み込みやすくするための工夫も必要で、表面に糖衣を施す、油を塗るなど、コーティングしてもよい。このように本実施例によれば、凝固剤溶液で固められた菌封入物を乾燥または脱溶媒した菌封入物を特徴とする物を提供することができる。
【0028】実施例11:油吸着タイプ 実施例10で得られた乾燥させたものを、食用油に漬ける。これにより、耐水性が高まり、耐化学剤性も高まる。油としては、大豆油、オリーブ油、ゴマ油、胚芽油、ヤシ油、菜種油、グレープシード油等である。なお、油に漬けるときに、油が浸透しやすいように、油の温度を35℃〜50℃ぐらいにしてもよい。このように本実施例により、実施例10で得られた乾燥させた菌封入物を食用油に漬け、耐水性を高めることを特徴とした菌封入物を提供することができる
【0029】実施例12:錠剤タイプ 錠剤タイプにすると摂取しやすくなる。また、錠剤化するときに、様々な栄養物と一緒に固めることができ、同時に有効に摂取できる。実施形態として、実施例10の乾燥タイプや実施例11の油吸着タイプをそのまま錠剤化するか、大豆、麦類、トウモロコシ、米、フスマ等の胚芽、ココア、野菜、ジャガイモ、オリゴ糖 花粉、コンニャク、果実の粉等の食用性粉末と各種ビタミン、ミネラル、糊料を一緒に固め、錠剤化してもよい。立方体、球体、紡錘形、円盤形、三角形、六角形等の形の錠剤にしてもよい。飲み込みやすくするため、または、さらに耐化学剤性を増すために、表面に糖衣を施すなど、コーティングしてもよい。このように本実施例により、実施例10の乾燥タイプまたは実施例11の油吸着タイプをそのまま、またはそれらに食物の粉末、ビタミン類、ミネラル類、糊料、あるいは食物抽出物等を少なくとも一つを混ぜ固め、錠剤化したことを特徴とする菌封入物を提供することができる。
【0030】実施例13:濃縮、脱溶媒タイプ 実施例1から実施例9で得られたものを、遠心力や圧力で、水分または水以外の溶媒を脱溶媒すると、腸内有用菌の濃度が増す。また強度を増すこともできる。ゲルの場合、急に力を加えると崩れ場合もあるので、形が崩れないよう、力の調節が必要になる。実施例9において、まず、脱溶媒したものを乾燥させてもよい。脱溶媒は脱水を含む。すなわち、凝固剤溶液で固められた菌封入物を濃縮、脱溶媒することを特徴とする菌封入物を提供する。
【0031】実施例14:粉末タイプ 実施例10において得られた乾燥させたものを、粉末あるいは顆粒状にする。そのまま、用いてもよいし、粉を他の食品に混ぜたりして固形化する。粉末あるいは顆粒状にすることで他のものと混ぜやすくなる。すなわち、凝固剤溶液で固められた菌封入物を粉末あるいは顆粒状にすることを特徴とした物を提供する。
【0032】
【発明の効果】
菌を凝固剤で固めた固形物に分散させ、胃液や胆汁などの酸アルカリ、または熱など外界の刺激から菌を保護する構造により、多くの有用菌を生きたまま腸内に大量に運ぶことができる。噛むことによっても、その機能は保たれる。凝固発酵または、凝固剤で菌を固める製造方法は、簡便であり、安価で有効性の高い製品を提供できる。さらに食物繊維を混入することで、腸内有用菌が腸内で繁殖、定着しやすい環境も提供でき、食物繊維による腸内浄化作用、ダイエット効果も期待できる。乾燥させた菌封入物は常温保存ができ、乾燥させない菌封入物よりさらに耐化学剤性が高まり、整腸作用がアップする。また錠剤化することで携帯可能なサプリメントになる。これらの製品は、人間以外の動物にも使用でき、ペットフードにも利用できる。
【図面の簡単な説明】
【図1】本発明の構造概念図である。
【図2】従来型の構造概念図である。
【図3】本発明の工程図である。
【符号の説明】
1 菌
2 凝固化固形物
3 被膜[0001]
[Technical field belonging to the invention]
This invention protects gastrointestinal useful bacteria such as yogurt, which is a health food, from acid-alkali such as gastric juice and bile, and supplies it to the intestine, thereby enhancing gastrointestinal resistance and bile resistance, etc. The present invention relates to a fungus inclusion having chemical resistance.
[0002]
[Prior art]
Conventionally, it is known that useful intestinal bacteria such as yogurt are killed by gastric juice and bile when eaten, and very few enteric bacteria are delivered alive in the intestine. For this reason, there has been a health food in which useful intestinal bacteria are enclosed in capsules or microcapsules. There was also the idea of encapsulating oligosaccharides that would serve as food for enteric bacteria. In addition, there are yogurt products in which a small amount of gelatin, pectin, or agar is added to yogurt, which is used as an additive to maintain a smooth texture and product shape. There is also a product obtained by solidifying bacteria powder with pressure. (For example, see Patent Documents 1 and 2)
[0003]
[Patent Document 1]
Japanese Patent Laid-Open No. 8-242663 [Patent Document 2]
Japanese Utility Model Publication No. 10-1149 [0004]
[Problems to be solved by the invention]
This has the following drawbacks.
(B) There is a method of trapping dried enteric bacteria in capsules or microcapsules, but the process is complicated and expensive. When chewed, the coating is broken and the effect of protecting the enteric bacteria from gastric juice is lost.
(B) Foods that help coagulate yogurt with a small amount of gelatin or agar have a good texture and taste when eaten. However, the strength of the gel is weak, and only by adding water or applying vibration, the shape collapses or the gel dissolves, and there is little effect of protecting useful intestinal bacteria from gastric juice and bile.
(C) When yogurt is mixed with a coagulant such as agar and coagulated, it is difficult to produce a homogeneous product because the yoghurt and the coagulant partially separate. This method is merely mixed and cannot increase the density of the bacteria, and it is difficult to incorporate the bacteria into the details of the gel network structure.
(D) Since the encapsulation method is only useful intestinal bacteria and oligosaccharides, it does not contain dietary fiber that is a breeding place for useful enteric bacteria.
[0005]
[Means for Solving the Problems]
As shown in the structural conceptual diagram of FIG. 1, bacteria are dispersed in a solid such as a solidified solid substance solidified with a coagulant, acid such as gastric juice, alkali such as bile, chemical agent such as bactericide, or external environment such as heat. The structure protects bacteria from these stimuli. The bacterium used in the present invention is not particularly limited, and examples thereof include lactic acid bacteria, bifidobacteria, faecalis bacteria, acidophilus bacteria, kefir bacteria used in yogurt, and caspian sea yogurt bacteria. When the solidified solid is a gel, bacteria are surrounded by the gel, and the diffusion rate according to the concentration gradient of acid, alkali, etc. contained in gastric juice and bile is reduced. Therefore, the permeation | permeation rate which an acid, an alkali, or a disinfectant osmose | permeates becomes slow, and chemical agent resistance increases. The chemical resistance includes gastric juice resistance, that is, acid resistance, bile resistance, that is, alkali resistance, antibacterial agent, and the like.
[0006] When ingested, even if it is crushed by chewing, since the bacteria are dispersed in the solidified solid, the bacteria are always protected by the solidified solid. On the other hand, as shown in FIG. 2, in the method of covering bacteria with a film such as a microcapsule, the film is broken when chewed during ingestion and does not have chemical resistance.
As a manufacturing method, a coagulant such as agar, which can be eaten, and a fungus are added to the culture solution to coagulate and ferment, or fermentation and coagulation are performed simultaneously. By this coagulation fermentation, fermentation is carried out in a state where the bacteria are dispersed in the coagulant-containing culture solution, the number of bacteria increases, active ingredients such as lactic acid are also produced, and the bacteria enter into every corner of the gel network structure and are homogeneous products Is easily obtained.
When fungi such as lactic acid bacteria solidified with a coagulant are dried or desolvated to reduce moisture, etc., they can be stored at room temperature, and the permeation rate through which gastric juice and bile permeate is further reduced. Sexuality further increases. In addition, the density of the bacteria can be increased. Even when the amount of the coagulant is small, the strength of the solid is increased and the chemical resistance is increased by drying.
The coagulant includes a gelling agent or an adhesive such as mannan such as agar, pectin, gelatin, cocoon, garagenan, xanthan gum, alginic acid, locust bean gum, starch, funori and gum arabic. In addition, the combination of coagulants is desirably resistant to gastric juice and bile and enteric in the intestine so that useful enteric bacteria can reach the intestine alive.
A fungus inclusion having chemical resistance and comprising the above structure or production method and a production method thereof.
[0011]
DETAILED DESCRIPTION OF THE INVENTION
Embodiments of the present invention will be described below.
Embodiment 1 A description will be given with reference to FIG.
1st process Agar which is coagulant and dietary fiber is mixed with water, and it boils and melt | dissolves and manufactures a coagulant solution. In this example, the weight ratio of water to agar was 25: 1 to make a 4% coagulant solution. In this step, it is necessary to raise the temperature to a temperature at which the coagulant melts. The amount of the coagulant is required to be more than the degree of coagulation in the ninth step. The jelly strength indicating the hardness of the gel is 250 to 400 g / cm 2 for natural agar, such as angular agar and yarn agar. Although it depends on the properties of the coagulant, in the case of agar, in order to provide gastric juice resistance, a value near or above this value is desirable.
2nd process Sugar and sugar sugar are mixed and a mixed sugar is manufactured. In this example, the weight ratio of sugar to sugar sugar was 5: 1. The sugar used in this process has both the role of sweetness and the role of fungus culture medium.
Third Step The sugar mixture in the second step is mixed with the coagulant solution in the first step to produce a sugar coagulant solution. In this example, the sugar coagulant solution was 20%.
4th process Milk which is a culture solution is warmed to a temperature at which the solution does not coagulate when the sugar coagulant solution is mixed. In this example, it was performed at 50 ° C.
Fifth Step A culture coagulant solution is produced by adding an equal weight of the fourth step culture solution to the sugar coagulant solution produced in the third step.
Sixth Step An equal weight of yogurt is put into milk as a culture solution and stirred, and heated to a temperature suitable for fermentation to produce a seed solution. By making the seed into a solution, it becomes easy to disperse in the culture coagulant solution. There is an optimal temperature for the growth of the fungus, and if the temperature is raised too much, it will die. On the other hand, if the temperature of the seed solution is too low, when mixed with the culture coagulant solution, it coagulates at the stage of stirring, and the bacteria cannot be sufficiently dispersed in the culture coagulant solution. In this example, it was performed at 35 ° C.
Seventh Step Cool the culture coagulant solution in the fifth step to an extent that does not coagulate. If the culture coagulant solution is too hot, the bacteria will die when mixed with the seed solution. In this example, it was performed at 50 ° C.
Eighth Step The culture coagulant solution of the seventh step and the seed solution of the sixth step are mixed at a weight ratio of 3: 1 and stirred to disperse and inoculate the bacterial seeds. At this time, you may add a fragrance | flavor, an extract, and a fruit according to liking. In this example, the culture coagulant solution is 50 ° C. and the seed solution is 35 ° C., and is around 45 ° C. when stirred. Depending on the type of coagulant and fungus, it is necessary to determine the temperature and weight ratio of the culture coagulant solution and the seed solution so that the culture coagulant solution does not solidify and the bacteria are difficult to die.
Ninth Step Coagulation fermentation is performed with the mixed solution in the eighth step at an appropriate temperature. In this example, it was performed at 35 ° C. The fermentation temperature, which is the appropriate temperature, varies depending on the type of bacteria. In this example, the mixture is already solidified at about 35 ° C., and the fermentation proceeds in the solidified state. When fermentation temperature is high and it does not solidify at the time of fermentation, it is preferable to raise the fermentation temperature after lowering the temperature once to solidify. The sol-gel transition occurs due to temperature, pressure, chemical substance, light beam, electric field, etc., and is often accompanied by a hysteresis phenomenon. For example, in the case of agar, depending on the concentration, it forms a sol at around 80 ° C. and gels at around 40 ° C. Therefore, once the temperature is lowered and solidified, it does not melt even if the temperature is raised and can be fermented in a solid state.
It is desirable to immediately move to the ninth step so that useful intestinal bacteria are not killed by heat in the eighth step. However, even if it is killed to some extent, it can be fermented and increased in the ninth step. Although the seed solution is manufactured in the sixth step, the seed of the fungus may be put directly into the powder or solid state seed in the eighth step.
In order to further increase the chemical resistance, the proportion of a coagulant such as agar may be increased. Conversely, if the proportion of the coagulant is reduced, the mouthfeel becomes soft. You may use skim milk for diet instead of milk. In order to facilitate the propagation of useful intestinal bacteria, sugars, vitamins, minerals, and the like may be mixed in the culture solution. When you eat the food that has been coagulated and fermented, (i) Eat it as it is, or eat it with syrup etc. after slicing it to a suitable size such as chopping. (B) Make granular small pieces and mix with drinks. Or mix with other foods. (C) Eat the dried food mixed with other foods.
As described above, a gastric juice-resistant coagulant that can be eaten, such as agar, and useful intestinal bacteria are added to the culture solution, and the coagulant is added by coagulating and fermenting or simultaneously performing fermentation and coagulation. In this production method, useful intestinal bacteria are uniformly dispersed in the culture solution.
Example 2: Coagulant mixing type In the first step of Example 1, a plurality of coagulants are used. For example, agar and starch are used as a coagulant, mixed at a weight ratio of water, agar and starch in a weight ratio of 25: 1: 0.5, boiled and boiled to produce a coagulant solution. The weight ratio should be changed according to the type of starch and the hardness of the finished product. The second and subsequent steps are the same as in Example 1. In addition to agar and starch, a plurality of coagulants such as pectin, gelatin, funori and gum arabic may be combined. Thus, by mixing the coagulant, the chemical agent resistance can be adjusted, and an object characterized by an optimal coagulant combination that easily dissolves in the intestinal fluid can be provided.
Example 3 Dietary fiber-reinforced type Dietary fiber such as mannan and bran is added in the first step of Example 1. For example, water, agar, and mannan are mixed at a weight ratio of 251: 0.1, boiled and boiled to produce a coagulant solution. The second and subsequent steps are the same as in Example 1. That is, by strengthening dietary fibers such as mannan and bran, it is possible to provide an article characterized by supplying an environment in which useful intestinal bacteria can easily grow in the intestine.
Example 4: Mineral / Vitamin / Food Extract Extract Enhancement Type Minerals such as calcium, magnesium, iron, various vitamins, or food extracts or foods in the steps prior to coagulation in Examples 1 to 3. Add The food may be herbs or spices or fermented foods. In the case of magnesium, etc., it has a laxative function, and herbs have functions such as medicinal properties. That is, by strengthening at least one of minerals, vitamins, or food extracts, it is possible to provide a product that can simultaneously supply nutrients and functions to a living body such as a human being or an animal.
Example 5: Mixed type of bacteria Various bacteria coexist in the intestine. Therefore, in Examples 1 to 4, a plurality of bacteria may be used as seeds. That is, by combining a plurality of bacteria, it is possible to provide a product characterized by making a combination of bacteria that can easily settle in the intestines of each individual.
Example 6: Anaerobic Bacteria Type In Example 1 to Example 4, when anaerobic bacteria are used as a seed, the process is processed in an enclosed state such as carbon dioxide gas or nitrogen gas so that the anaerobic bacteria can be fermented. Put a reducing agent such as vitamin C or oxygen absorber, or cover the inside of the container with vinyl etc. in the fermentation process, close the air, or pour into a container that can be sealed, coagulated fermentation or coagulated Is taken out, transferred to a container that can be sealed, fermented, and anaerobic bacteria such as bifidobacteria are grown. Anaerobic bacteria mainly propagate in the intestines. That is, a method characterized by growing anaerobic bacteria is provided.
Example 7: Coexistence type of anaerobic bacteria and aerobic bacteria In Examples 1 to 4, a mixed species of anaerobic bacteria and aerobic bacteria is used. When coagulating and fermenting, the cells are cultured in a sealed container so that oxygen does not enter from outside. At first, anaerobic bacteria grow and anaerobic bacteria grow after oxygen is consumed. That is, a method characterized by coexisting aerobic bacteria and anaerobic bacteria is provided.
Example 8: Direct dispersion coagulation method A method in which bacteria powder or a mixture of bacteria powder in hydrophobic oil or the like is directly mixed in a coagulant and dispersed to coagulate. When a product obtained by mixing bacteria in a hydrophobic substance such as soybean oil, olive oil, sesame oil, germ oil, coconut oil, rapeseed oil, or grape seed oil is dispersed in a coagulant solution and solidified, the chemical resistance is increased. In the first step such as Example 1 or Example 2, after the coagulant solution is made, the temperature is lowered to a temperature that does not reach the freezing point. If it is agar, lower it to about 40 ° C. A mixture of fungus powder or hydrophobic oil mixed with fungus powder is added to the coagulant solution, stirred, dispersed and coagulated. Alternatively, in the eighth step of Example 1, in place of the seed solution, fungus powder is added, or a mixture of fungus powder in a hydrophobic oil or the like is added. This has the effect of simultaneously adding nutrients that allow bacteria to grow in the intestines.
In the case of anaerobic bacteria, carbon dioxide gas may be enclosed or a reducing agent such as vitamin C may be added. The coagulation solution may be mixed with at least one of dietary fiber, mineral, vitamin, or food extract. The coagulant solvent may be a substance other than water. The fungal powder may be mixed in a solvent and added to the coagulant solution. That is, disperse the coagulant solution, or the coagulant solution mixed with at least one of culture solution, dietary fiber, minerals, vitamins, food extract, and fungus powder or hydrophobic substance with fungus powder A method for producing a fungus inclusion, characterized in that it is made solid.
Example 9 Strength Enhancement Type Certain chemical substances such as calcium ions, magnesium ions, potassium ions, polymer charged substances, etc., promote solidification or enhance the strength of solids with a cross-linked structure, etc. The permeation rate of hydrogen ions, hydroxide ions, etc. may be reduced. It may be added in the solidification step of Examples 1 to 8 or may be dipped after solidification. As described above, according to this example, in Example 1 to Example 8 and the like, it is possible to provide a fungus inclusion that promotes coagulation with a chemical substance or enhances the strength of a solid.
Example 10: Drying type Drying allows the bacteria to sleep and can be stored at room temperature. The density of bacteria increases. The strength of the solid solidified with the coagulant becomes stronger, the penetration rate of the chemical agent such as acid, alkali, and bactericidal agent is further lowered, and the chemical agent resistance such as acid resistance and alkali resistance is increased. Even when the amount of the coagulant is small, the chemical-resistant agent and the like are increased by being concentrated. What was obtained by coagulation fermentation or coagulation in Example 1 to Example 9 was cut into an appropriate size and dried. Or what was obtained by coagulation fermentation or coagulation in Example 1 to Example 9 may be dried and then cut into an appropriate size. The drying method may be a process such as shade drying, cold air drying, hot air drying, room temperature vacuum drying, low temperature vacuum drying or freeze drying. The solvent may be squeezed out using centrifugal force, squeezing, etc., or the above drying method may be used after squeezing out. It can be dried quickly by squeezing out the solvent.
The product obtained in Example 1 was sliced to an appropriate size, dried in the shade, and a rubbery object was obtained. It was immersed for 1 hour in a household chlorine bleach (Kaneyo Kitchen Bleach) that was about 1.5 mm thick and about 15 mm square thinned twice. After that, it was washed with water, soaked in water for 1 hour, put in a bottle sterilized with hot water together with milk, sealed, and allowed to stand at room temperature for 48 hours. Similarly, a comparison experiment was conducted using only milk, but it did not ferment.
The dried product may be ingested in granular form. The size is such that it can be swallowed from the size that can keep the chemical resistance. For example, the minimum size should be about the thickness of a microcapsule type coating. The shape may be a tablet such as a cube, sphere, spindle, disk, triangle, hexagon. In order to make it easy to swallow, it is necessary to apply sugar coating or oil on the surface. Thus, according to the present Example, the thing characterized by the fungus inclusion which dried or desolvated the fungus inclusion solidified with the coagulant | cure agent solution can be provided.
Example 11: Oil adsorption type The dried product obtained in Example 10 is dipped in cooking oil. Thereby, water resistance increases and chemical agent resistance also increases. Examples of the oil include soybean oil, olive oil, sesame oil, germ oil, coconut oil, rapeseed oil, and grape seed oil. In addition, when immersed in oil, you may make the temperature of oil into about 35 degreeC-50 degreeC so that oil may osmose | permeate easily. Thus the present embodiment, the bacterial inclusions drying obtained in Example 10 immersed in edible oil, it is possible to provide a bacterial inclusions were characterized by increasing the water resistance [0029] Example 12: Tablet type Easier to take when tablet type. Moreover, when tableting, it can be hardened together with various nutrients and can be ingested effectively at the same time. As an embodiment, the dry type of Example 10 and the oil adsorption type of Example 11 are tableted as they are, or germs of soybean, wheat, corn, rice, bran, cocoa, vegetables, potato, oligosaccharide pollen, konjac Alternatively, edible powder such as fruit powder and various vitamins, minerals, and pastes may be hardened together and tableted. You may make it a tablet of shapes, such as a cube, a sphere, a spindle shape, a disk shape, a triangle, and a hexagon. In order to make it easy to swallow or to further increase the chemical resistance, the surface may be coated with a sugar coating. As described above, according to the present example, the dry type of Example 10 or the oil adsorption type of Example 11 is used as it is or at least one of food powder, vitamins, minerals, paste, food extract, etc. is added thereto. It is possible to provide a fungus inclusion characterized by mixing and solidifying and tableting.
Example 13: Concentration, Desolvation Type When the solvents obtained in Examples 1 to 9 were desolvated with water or a solvent other than water by centrifugal force or pressure, the concentration of useful enteric bacteria was increased. Increase. In addition, the strength can be increased. In the case of gels, suddenly applying force may collapse, so it is necessary to adjust the force so that the shape does not collapse. In Example 9, first, the solvent removed may be dried. Desolvation includes dehydration. That is, a fungus inclusion characterized by concentrating and desolvating the fungus inclusion solidified with a coagulant solution.
Example 14: Powder type The dried product obtained in Example 10 is powdered or granulated. You can use it as it is, or mix it with other foods to solidify it. It becomes easy to mix with other things by making powder or granule. That is, the present invention provides a product characterized in that the bacterial inclusion solidified with a coagulant solution is powdered or granulated.
[0032]
【The invention's effect】
Disperse bacteria in solids solidified with a coagulant and transport many useful bacteria in large quantities in the intestine with a structure that protects bacteria from acid and alkali such as gastric juice and bile, or external stimuli such as heat. Can do. The function is maintained by biting. Coagulation fermentation or a production method for solidifying bacteria with a coagulant is simple, can provide an inexpensive and highly effective product. Furthermore, by incorporating dietary fiber, it is possible to provide an environment in which useful intestinal bacteria can easily propagate and settle in the intestine, and the intestinal purification action and diet effect by dietary fiber can also be expected. The dried fungus inclusion can be stored at room temperature, and the resistance to chemical agents is further increased and the intestinal regulation action is improved compared to the fungus inclusion not dried. Moreover, it becomes a portable supplement by tableting. These products can be used for animals other than humans and also for pet food.
[Brief description of the drawings]
FIG. 1 is a conceptual diagram of the structure of the present invention.
FIG. 2 is a conceptual diagram of a conventional structure.
FIG. 3 is a process diagram of the present invention.
[Explanation of symbols]
1 fungus 2 solidified solid 3 coating
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003054955A JP2004173675A (en) | 2002-10-02 | 2003-01-24 | Bacterium-encapsulated product having chemical-resistant property and method for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002324521 | 2002-10-02 | ||
JP2003054955A JP2004173675A (en) | 2002-10-02 | 2003-01-24 | Bacterium-encapsulated product having chemical-resistant property and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004173675A true JP2004173675A (en) | 2004-06-24 |
JP2004173675A5 JP2004173675A5 (en) | 2005-09-02 |
Family
ID=32716046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003054955A Pending JP2004173675A (en) | 2002-10-02 | 2003-01-24 | Bacterium-encapsulated product having chemical-resistant property and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004173675A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678817B2 (en) | 2005-06-03 | 2010-03-16 | Medrx Co., Ltd. | Enteric medicinal composition for oral use |
US9232813B2 (en) | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
US9404162B2 (en) | 2005-05-31 | 2016-08-02 | Mars, Incorporated | Feline probiotic bifidobacteria and methods |
US9415083B2 (en) | 2004-05-10 | 2016-08-16 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal |
US9427000B2 (en) | 2005-05-31 | 2016-08-30 | Mars, Incorporated | Feline probiotic lactobacilli composition and methods |
US9580680B2 (en) | 2003-12-19 | 2017-02-28 | Mars, Incorporated | Canine probiotic bifidobacterium pseudolongum |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US9821015B2 (en) | 2003-12-19 | 2017-11-21 | Mars, Incorporated | Methods of use of probiotic bifidobacteria for companion animals |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
-
2003
- 2003-01-24 JP JP2003054955A patent/JP2004173675A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9580680B2 (en) | 2003-12-19 | 2017-02-28 | Mars, Incorporated | Canine probiotic bifidobacterium pseudolongum |
US9821015B2 (en) | 2003-12-19 | 2017-11-21 | Mars, Incorporated | Methods of use of probiotic bifidobacteria for companion animals |
US9415083B2 (en) | 2004-05-10 | 2016-08-16 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal |
US9404162B2 (en) | 2005-05-31 | 2016-08-02 | Mars, Incorporated | Feline probiotic bifidobacteria and methods |
US9427000B2 (en) | 2005-05-31 | 2016-08-30 | Mars, Incorporated | Feline probiotic lactobacilli composition and methods |
US7678817B2 (en) | 2005-06-03 | 2010-03-16 | Medrx Co., Ltd. | Enteric medicinal composition for oral use |
US9232813B2 (en) | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10709156B2 (en) | 2008-07-07 | 2020-07-14 | Mars, Incorporated | Pet supplement and methods of making |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020373489B2 (en) | Microcapsule, preparation method and application thereof | |
Lopez-Rubio et al. | Bioactive packaging: turning foods into healthier foods through biomaterials | |
CN103222506A (en) | Preparation method of coagulated type yogurt containing agar | |
CN101856604A (en) | Method for preparing probiotic microcapsules by using electrostatic spraying | |
CN103929982A (en) | Natural garden stuff enzyme beverage and preparation method therefor | |
CN103689345B (en) | A kind of preparation method of cereal sauce and prepared cereal sauce thereof | |
CN103444985B (en) | Feed additive and manufacturing method and application thereof | |
CN103549245A (en) | Lactobacillus fermented agar gel food and preparation method thereof | |
EP2347661B1 (en) | Method for obtaining a mixture of probiotics, nutrient prebiotics having synergistic symbiotic action | |
JP2004173675A (en) | Bacterium-encapsulated product having chemical-resistant property and method for producing the same | |
CN107594109A (en) | A kind of pet drinks enzyme liquid and preparation method thereof | |
Jiménez-Villeda et al. | Synbiotic encapsulation: a trend towards increasing viability and probiotic effect | |
CN106509103A (en) | Preparation method for brown rice flavor fermented yoghourt | |
CN106616171A (en) | Probiotic beverage containing saussurea involucrate culture and preparation method thereof | |
CN105230782A (en) | Preparation method of hair weed yoghourt | |
CN105053767A (en) | Preparation method of nutrient coconut milk fruits | |
CN109864137A (en) | A kind of quick-fried pearl Yoghourt and preparation method thereof | |
CN107125735A (en) | A kind of matrimony vine composite enzyme and preparation method thereof | |
CN109730281A (en) | Fermented tea emblic jelly and preparation method thereof | |
CN104430867A (en) | Preparation method of living bacterium type red jujube acid milk beverage | |
CN101869140A (en) | Yogurt with functional materials and preparation method thereof | |
CN104397178A (en) | Kiwi fruit yoghourt | |
CN111838496A (en) | Probiotic solid beverage beneficial to oral health and preparation method thereof | |
CN103704718A (en) | Preparation method of bacillus subtilis microcapsule with high viable count in shelf life | |
CN109380507A (en) | Room temperature coconut Yoghourt and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050301 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050301 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050301 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070828 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071225 |